These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1579188)

  • 1. Pulmonary embolism treated with a single dose of anisoylated lys-plasminogen streptokinase activator complex and systemic heparinization; a report of two cases.
    Schalij MJ; van de Meeberg PC; Marsman JW; Maingay D
    Neth J Med; 1992 Feb; 40(1-2):69-75. PubMed ID: 1579188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolytic treatment of acute pulmonary embolism.
    Charbonnier B; Meyer G; Stern M; Sors H; Brochier ML
    Herz; 1989 Jun; 14(3):157-71. PubMed ID: 2500388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary embolism. A propos of a case treated with APSAC].
    Santo ME; da Silva G; Pimenta A
    Rev Port Cardiol; 1991 Apr; 10(4):339-42. PubMed ID: 1888524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of moderate doses of urokinase combined with heparin in the treatment of massive pulmonary embolism. A retrospective study of 33 cases].
    Laaban JP; Poubeau P; Horellou MH; Ecoiffier J; Conard J; Samama M; Rochemaure J
    Ann Med Interne (Paris); 1989; 140(7):551-6. PubMed ID: 2692486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis.
    Jackson CV; Frank JD; Craft TJ; Sundboom JL; Smith GF
    J Pharmacol Exp Ther; 1992 Jan; 260(1):64-70. PubMed ID: 1731052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of thrombolysis for the treatment of acute pulmonary embolism].
    Marbet GA
    Schweiz Med Wochenschr; 1989 Oct; 119(43):1498-505. PubMed ID: 2514456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful thrombolysis of submassive pulmonary embolism after bariatric surgery: expanding the indications and addressing the controversies.
    Pulipati RC; Lazzaro RS; Macura J; Savel RH
    Obes Surg; 2003 Oct; 13(5):792-6. PubMed ID: 14627480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic use of thrombolytic agents.
    Stambaugh RL; Alexander MR
    Am J Hosp Pharm; 1981 Jun; 38(6):817-24. PubMed ID: 7018230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
    Carter BL; Jones ME; Waickman LA
    Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multicenter study of 2 urokinase protocols in severe pulmonary embolism. Research Group on Urokinase and Pulmonary Embolism].
    Arch Mal Coeur Vaiss; 1984 Jul; 77(7):773-81. PubMed ID: 6433840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombolytic drugs in acute myocardial infarct].
    Ambrosioni E; Degli Esposti D
    Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low doses of rtPA administered as a bolus in treatment of clinically acute massive pulmonary embolism].
    Tomkowski W; Borowiec B; Hajduk B; Kober J; Burakowski J; Oniszh K; Pawlicka L; Filipecki S
    Pneumonol Alergol Pol; 1996; 64 Suppl 2():161-5. PubMed ID: 9181884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolytic treatment of pulmonary embolism with APSAC.
    Vander Sande J; Bossaert L; Brochier M; Charbonnier B; Serradigmini A; Elias A; Pintens H; Lauwers MC
    Eur Respir J; 1988 Aug; 1(8):721-5. PubMed ID: 3069487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive pulmonary embolism: treatment with full heparinization and topical low-dose streptokinase.
    Vujic I; Young JW; Gobien RP; Dawson WT; Liebscher L; Shelley BE
    Radiology; 1983 Sep; 148(3):671-5. PubMed ID: 6878682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Very low doses of tissue plasminogen activator in treatment of acute massive pulmonary embolism].
    Tomkowski W; Borowiec B; Kober J; Filipecki S; Wiechecka A; Pawlicka L
    Pneumonol Alergol Pol; 1996; 64 Suppl 2():207-10. PubMed ID: 9181892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preclinical toxicology of anisoylated plasminogen streptokinase activator complex.
    Artus JA; Cockburn A; Fuller J; McMurdo AS; White DJ
    Drugs; 1987; 33 Suppl 3():97-101. PubMed ID: 3315619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of streptokinase and heparin on the early rate of resolution of major pulmonary embolism.
    Hirsh J; McDonald IG; Hale GA; O'Sullivan EF; Jelinek VM
    Can Med Assoc J; 1971 Mar; 104(6):488-91 passim. PubMed ID: 5549989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism.
    Miller GA; Sutton GC; Kerr IH; Gibson RV; Honey M
    Br Med J; 1971 Jun; 2(5763):681-4. PubMed ID: 5556052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subacute massive pulmonary embolism treated with plasminogen and streptokinase.
    Ellis DA; Neville E; Hall RJ
    Thorax; 1983 Dec; 38(12):903-7. PubMed ID: 6665749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of phlebography for diagnosis and treatment of pulmonary embolism.
    Serradimigni A; Chiche G; Romani A; Philip F
    Int Angiol; 1985; 4(3):323-8. PubMed ID: 3831154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.